EGFR and cancer: In cancer cells two cell signalling pathways, the epidermal growth factor receptor (EGFR) and the insulin-like growth factor receptor 1 (IGF1-R) signalling, have been reported to be responsible for proliferation inhibition upon miR-7 induction [14], [16], [23].